Tiopronin Injection

Animal experiments have shown that this product can reduce the increase of serum AST and ALT in the animal acute liver injury model caused by thioacetamide and carbon tetrachloride, and inhibit the accumulation of triglycerides caused by chronic liver injury model; it can promote liver glycogen synthesis, inhibit the increase of cholesterol, and help to restore the serum albumin/globulin ratio.

Tiopronin.

This product is a colorless clear liquid.

1. Used to improve liver function of various acute and chronic hepatitis. 2. Used for the treatment of fatty liver, alcoholic liver, drug-induced liver damage and detoxification of heavy metals. 3. Can reduce the toxic and side effects of radiotherapy and chemotherapy, and can prevent the occurrence of peripheral leukopenia and secondary tumors caused by radiotherapy and chemotherapy. 4. Has a significant therapeutic effect on early senile cataracts and vitreous opacities.

Intravenous drip, 0.2 g at a time, once a day, for 4 weeks. Add to 5%~10% glucose solution or 250~500 ml of normal saline, and drip intravenously as usual.

1 Allergic reaction: rash, itchy skin, flushed face. 2 Digestive system: nausea, vomiting, abdominal pain, diarrhea, loss of appetite and other gastrointestinal reactions, rare taste abnormalities.

Patients who have experienced allergic reaction or severe adverse reaction to tiopronin are contraindicated.

Do not use in combination with drugs that have oxidizing effects.

Keep in a dark, airtight container in a cool place.

5ml:0.2g

Heilongjiang Ruige Pharmaceutical Co., Ltd.

• Founded in:

  2003-07-09

• Address:

  Dongcheng District, Qing'an County, Suihua City, Heilongjiang Province

• Tax NO.:

  912312247523861613

• Registered Funds:

  56.68 million yuan

• Email:

  Log in to view